A randomized, placebo-controlled trial to evaluate the tolerability, safety, pharmacokinetics, and pharmacodynamics of a potent inhibitor of poly(ADP-ribose) polymerase (INO-1001) in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of the TIMI 37 trial
David A. Morrow, Chaim M. Brickman, Sabina A. Murphy, Kenneth Baran, Ricardo Krakover, Harold Dauerman, Sujatha Kumar, Natanya Slomowitz, Laura Grip, Carolyn H. McCabe, Andrew L. SalzmanТом:
27
Мова:
english
Сторінки:
6
DOI:
10.1007/s11239-008-0230-1
Date:
May, 2009
Файл:
PDF, 258 KB
english, 2009
File converter
Більше результатів пошуку
More benefits 
